Literature DB >> 12809699

Morphine induction of c-fos expression in the rat forebrain through glutamatergic mechanisms: role of non-n-methyl-D-aspartate receptors.

M M Garcia1, A T Anderson, R Edwards, R E Harlan.   

Abstract

Acute injection of morphine induces expression of the immediate-early genes c-Fos and JunB in several forebrain regions of the rat, in part through an N-methyl-D-aspartate (NMDA) receptor-dependent mechanism. Because membrane depolarization through (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptors is believed to be necessary for full activation of NMDA receptors, we determined the role of AMPA receptors in morphine-induced c-Fos expression. Rats were given the AMPA receptor antagonist GYKI-52466 (12.9 mg/kg, i.p.) 15 min before morphine (10 mg/kg, s.c.), or the AMPA receptor enhancer CX516 (30 mg/kg, i.p.) 5 min after morphine. The c-Fos response was attenuated by the antagonist and augmented by the enhancer. Using double immunocytochemistry, we found that morphine induced c-Fos in neurons containing the GluR2/3, but not the GluR1 and rarely the GluR4, subunits of the AMPA receptor. Double immunocytochemistry for mu opioid receptor and c-Fos showed that c-Fos expression was mainly absent in the patch compartment of the striatum, which is enriched in mu opioid receptors. The glutamatergic synapse often contains metabotropic receptors as well as ionotropic receptors. Type I metabotropic glutamate receptors are coupled to activation of protein kinase C, which has also been shown to mediate the immediate-early gene response to morphine. To determine if activation of metabotropic glutamate receptors is involved in rapid effects of morphine on the brain, rats were given the type I metabotropic glutamate receptor antagonist (RS)-1-aminoindan-1,5-dicarboxylic acid (AIDA; 0.2 mg/kg, i.p.) or vehicle 30 min before morphine treatment. Pretreatment with AIDA completely blocked morphine-induced c-Fos expression in the caudate-putamen.Taken together, these results demonstrate involvement of both AMPA and type I metabotropic glutamate receptors in the acute effects of morphine on the forebrain, supporting an important role for glutamatergic neurotransmission mediated by non-NMDA glutamate receptors in morphine's actions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12809699     DOI: 10.1016/s0306-4522(02)00975-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Fos and glutamate AMPA receptor subunit coexpression associated with cue-elicited cocaine-seeking behavior in abstinent rats.

Authors:  A R Zavala; S Biswas; R E Harlan; J L Neisewander
Journal:  Neuroscience       Date:  2007-02-01       Impact factor: 3.590

2.  Gabapentin completely attenuated the acute morphine-induced c-Fos expression in the rat nucleus accumbens.

Authors:  Jamil Ahsan Kazi; Mohamed Ibrahim Abu-Hassan
Journal:  J Mol Neurosci       Date:  2010-08-24       Impact factor: 3.444

Review 3.  Vitamin C, Pain and Opioid Use Disorder.

Authors:  Erica Zelfand
Journal:  Integr Med (Encinitas)       Date:  2020-06

4.  Gabapentin completely attenuated the acute morphine induced c-Fos expression in the rat striatum.

Authors:  Jamil Ahsan Kazi; Chen Fun Gee
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

Review 5.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

6.  Opposing mechanisms underlying differential changes in brain oxygen and temperature induced by intravenous morphine.

Authors:  Ernesto Solis; Anum Afzal; Eugene A Kiyatkin
Journal:  J Neurophysiol       Date:  2018-09-05       Impact factor: 2.714

7.  The effect of vitamin C on morphine self-administration in rats.

Authors:  Mahboobeh Talkhooncheh; Hojjat Allah Alaei; Effat Ramshini; Somaei Shahidani
Journal:  Adv Biomed Res       Date:  2014-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.